P

Paradigm Clinical Research Centers, LLC | Redding, CA

Research site

(Unclaimed)

Location

3652 Eureka Way, Redding, California, United States of America

Site insights

Top conditions

Top treatments

Deupirfenidone

Ridinilazole

Vancomycin

Pirfenidone

NOC-110

Buloxibutid

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 14 total trials

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis. (ASPIRE)

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and phar...

Enrolling

Idiopathic Pulmonary Fibrosis (IPF)

Drug: Placebo

Drug: Buloxibutid

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (ELEVATE)

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Drug: Deupirfenidone

Drug: Placebo

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough (ASPIRE)

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling

Refractory or Unexplained Chronic Cough

Drug: NOC-110

Other: Placebo